You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 10, March 8, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Aspects of Genetic Variability in Helicobacter pylori

Stuart Jon Spechler, MD; Lori Fischbach, PhD; Mark Feldman, MD

JAMA. 2000;283:1264-1266.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Helicobacter Pylori organisms have been infecting human stomachs for centuries. Antigens of these microaerophilic, gram-negative bacteria have been found in stool samples of ancient mummies.1 Today, it appears that more than half of the world's population is infected with H pylori.2 These organisms are adapted for survival in the stomach in which infection causes a chronic gastritis that persists for decades.

H pylori infection is strongly associated with peptic ulcer disease, and is widely accepted as a risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma.3 Antibiotic therapy aimed at eradicating H pylori is recommended for infected patients who have verified peptic ulcerations of the stomach or duodenum, or who have gastric MALT lymphomas.4 Nevertheless, it has been estimated that less than 20% of individuals who are chronically infected with H pylori ever develop a peptic ulcer . . . [Full Text of this Article]

Genetic Variability and Virulence

Clinical and Epidemiological Aspects of CagA Positivity

Current Recommendations and Directions for Future Research

Author Affilations: Department of Veterans Affairs Medical Center, Dallas (Drs Spechler and Feldman), University of Texas Southwestern Medical Center (Drs Spechler, Fischbach, and Feldman), School of Public Health (Dr Fischbach); and the University of Texas Health Science Center, Houston (Dr Fischbach).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

March 8, 2000
JAMA. 2000;283(10):1361-1362.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach
Souza and Spechler
CA Cancer J Clin 2005;55:334-351.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.